Neuroleptic malignant syndrome in a patient with stable dose of olanzapine

Neuroleptic malignant syndrome in a patient with stable dose of olanzapine

Neuroleptic malignant syndrome (NMS), a potentially fatal consequence due to typical neuroleptics, has been described so far. In the past few years, there has been increased use of atypical antipsychotic drugs. Cases of NMS related to atypical neuroleptics, such as olanzapine, are less common in spi...

Full description

Bibliographic Details
Main Authors: Manoj Kumar Sahoo, Sangita Kamath, Abhijeet Sharan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Bipolar affective disorder
neuroleptic malignant syndrome
olanzapine
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2017;volume=6;issue=1;spage=158;epage=160;aulast=Sahoo

Similar Items

Similar Items